ABL Diagnostics

ABL Diagnostics is a specialized medical technology company headquartered in Woippy, France, dedicated to the development, manufacturing, and commercialization of end-to-end molecular diagnostic solutions. As a subsidiary of Advanced Biological Laboratories (ABL) S.A., the company focuses on infectious disease management, providing a comprehensive suite of tools that include molecular assays for genotyping and PCR-based detection, as well as sophisticated digital health software. Their portfolio is designed to assist laboratories, clinicians, and researchers in improving patient outcomes through high-technology diagnostic tools. The company maintains a significant presence in the clinical sector, notably through its Nadis® software, which serves as a standard electronic medical record and clinical database management system for HIV and viral hepatitis in hundreds of French hospitals. By integrating proprietary algorithms and knowledge databases with laboratory high-throughput systems, ABL Diagnostics bridges the gap between raw sequencing data and actionable clinical decision support. Listed on the Euronext Paris exchange, the company continues to expand its global footprint through a robust network of distributors and a commitment to innovation in microbiology and infectious disease diagnostics.

The mission of ABL Diagnostics is to develop, manufacture, and commercialize proprietary, end-to-end diagnostic solutions for infectious diseases, aiming to improve patient disease management and support medical progress through innovative, high-technology diagnostic tools.

• Listed on compartment B of the Euronext Paris regulated market since 2022.
• Nadis® software is utilized in over 200 hospitals across France for chronic infectious disease management.
• Maintains one of the largest microbiology application portfolios covering HIV, TB, Hepatitis, and respiratory viruses.
• Successfully integrated multiple diagnostic assets and CRO services through strategic acquisitions like CDL Pharma.

Sources

• ABL Diagnostics Official Website
• Euronext Paris Company Profile